Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development.

The biosynthesis of androgens is central to male sex development. Established pathways involve testosterone as a precursor to dihydrotestosterone (DHT). However, recent studies suggest an alternative route exists. Prior research has shown that testosterone is the primary source for DHT in most tissues. Yet, some species exhibit DHT production without testosterone intermediacy. This discrepancy has raised questions about alternative biosynthetic routes. The tammar wallaby and mouse models have demonstrated a backdoor pathway bypassing testosterone. These findings challenge traditional models of androgen synthesis. No prior work had resolved whether this pathway operates in humans. This gap motivated further investigation into the human relevance of the backdoor pathway.

This review aims to synthesize evidence for a backdoor pathway of DHT biosynthesis in humans. The specific problem is whether this pathway contributes to normal and abnormal sex development. The motivation stems from observations in animal models and clinical findings in human patients. Genetic mutations in pathway-related genes correlate with undermasculinization in males. Urinary steroid profiles suggest pathway activation in certain genetic disorders. The study seeks to clarify the physiological and pathological roles of this pathway. It also aims to evaluate its relevance to fetal and adrenal interactions. No prior work had resolved the extent of the pathway's involvement in human development.

The researchers conducted a literature review of existing studies on DHT biosynthesis. They analyzed molecular data from genetic mutations in human patients. Urine steroid profiles were examined to detect pathway activity. The tammar wallaby and mouse models were referenced for comparative insights. Pathway gene expression was evaluated in fetal and adult tissues. Clinical data from patients with sex development disorders were reviewed. No new experiments were performed; the focus was on synthesizing existing evidence. The review approach included both experimental and clinical findings.

The backdoor pathway bypasses testosterone to produce DHT directly from cholesterol. Evidence comes from molecular analysis of genetic mutations in affected males. Urinary steroid profiles in females with enzyme deficiencies suggest pathway activation. The pathway appears to operate in fetal testes to support normal male development. In pathological conditions, fetal and adrenal interactions may enhance pathway activity. Elevated 17-hydroxyprogesterone levels correlate with pathway activation. The pathway is likely a primary source of DHT in fetal development. These findings suggest a dual role in both normal and abnormal sex development.

The backdoor pathway provides a novel mechanism for DHT biosynthesis in humans. It operates independently of testosterone in certain developmental contexts. Molecular and clinical evidence supports its physiological and pathological roles. The pathway is likely active in fetal testes to support male sex development. In pathologic conditions, interactions with adrenal hormones may enhance pathway activity. The findings suggest a need to reconsider traditional models of androgen synthesis. No prior work had resolved the extent of the pathway's involvement in human development. These insights may improve understanding of sex development disorders.